In vitro assessment of P‐gp and BCRP transporter‐mediated drug–drug interactions of riociguat with direct oral anticoagulants-Reference-Cited by-同舟云学术

In vitro assessment of P‐gp and BCRP transporter‐mediated drug–drug interactions of riociguat with direct oral anticoagulants

Published:2019-08-28 Issue:1 Volume:34 Page:109-119
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Jacqueroux Elodie¹^ORCID,Mercier Clément¹,Margelidon‐Cozzolino Victor¹,Hodin Sophie¹,Bertoletti Laurent¹²,Delavenne Xavier¹³

Affiliation:

1. INSERM U1059 Laboratoire Sainbiose Equipe Dysfonctions Vasculaires et Hémostase Faculté de médecine de Saint‐Etienne Université de Lyon F‐42055 Saint‐Etienne France

2. Service de Médecine Vasculaire et Thérapeutique CHU de Saint‐Etienne F‐42055 Saint‐Etienne France

3. Laboratoire de Pharmacologie Toxicologie CHU de Saint‐Etienne F‐42055 Saint‐Etienne France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12504

Reference37 articles.

1. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2. Treatment of Pulmonary Arterial Hypertension

3. Lack of a Pharmacokinetic Interaction Between Treprostinil Diolamine and Sildenafil in Healthy Adult Volunteers

4. Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

5. Pharmacokinetic Interaction of Riociguat with Ketoconazole, Clarithromycin, and Midazolam

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct oral anticoagulants in the treatment of chronic thromboembolic pulmonary hypertension patients: A retrospective cohort study;Respiratory Medicine;2024-09

2. Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH;Blood Reviews;2024-09

3. Clinical Analysis and <i>in Vitro</i> Correlation of BCRP-Mediated Drug–Drug Interaction in the Gastrointestinal Tract;Biological and Pharmaceutical Bulletin;2024-04-01

4. Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension;Thrombosis Research;2023-09

5. Risk assessment and molecular mechanism study of drug-drug interactions between rivaroxaban and tyrosine kinase inhibitors mediated by CYP2J2/3A4 and BCRP/P-gp;Frontiers in Pharmacology;2022-08-22